Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DrMedHealth vs Teleios Health

DrMedHealth
Graded #195

Higher grade

vs+6
Teleios Health
Graded #327

Lower grade

The verdict

DrMedHealth takes it — 66.2/100 to 60.2/100.

DrMedHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DrMedHealth is a LegitScript-certified US telehealth platform for GLP-1 medical weight loss.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleios Health +30
54
84
Dose & formulationDrMedHealth +13
77
64
Clinical oversightDrMedHealth +33
82
49
Labs & monitoringDrMedHealth +5
53
48
FulfillmentDrMedHealth +29
71
42
Contract termsEven
55
55
DrMedHealth · left barTeleios Health · right bar

The numbers

MetricDrMedHealthTeleios Health
WeighScore66.2/10060.2/100
GradeCC
Scorecard rank#195#327
Semaglutide$199/mo (starting dose, compounded)$99/mo (starting dose, compounded)
Tirzepatide$299/mo (starting dose, compounded)$139/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
DrMedHealth

Graded #195 · C

Strengths

  • LegitScript certified telehealth platform
  • Low compounded pricing: semaglutide from $199/mo, tirzepatide from $299/mo
  • Both compounded and FDA-approved branded options available
  • Fast physician review (advertised ~2 hours) with free shipping
  • Compounded by licensed US pharmacies

Where it loses points

  • Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
  • Cash-pay model; insurance generally not accepted for medication
  • Full list of available states not consolidated in one place
  • Site is JavaScript-rendered, limiting easy review of full terms
Teleios Health

Graded #327 · C

Strengths

  • Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
  • Compounded tirzepatide from a competitive $139/mo floor
  • Markets physician (MD/DO) prescribing rather than an NP-only model
  • Clean meta-tag and SEO implementation

Where it loses points

  • Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
  • No named medical director, physician, or corporate entity disclosed
  • Year founded unknown — a newer floor-price entrant warranting extra scrutiny
  • No LegitScript, NABP, or SOC 2 trust signal found
  • Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard